Conference Coverage
Conference Coverage
Anal cancer cases continue to rise, with disproportionately poorer outcomes for blacks
Overall 5-year survival rates for anal cancer in the United States have steadily improved since the 1970s, but the incidence of disease continues...
Conference Coverage
Plasma microRNA assay differentiates colorectal neoplasia
CHICAGO – A novel plasma microRNA assay and prediction model appears to successfully differentiate colorectal neoplasia from other neoplasms and...
Conference Coverage
ABIM announces shorter MOC assessment
News
VIDEO: Secrets of success in a MACRA-based world
WASHINGTON – When it comes to switching your practice to value-based care, time is running out. But, according to our expert panel, don’t let...
Conference Coverage
VIDEO: Value-based care 101
WASHINGTON – By now, you’ve heard of “value-based care.” But do you know what it means and why, if you don’t take heed, your practice could be in...
Conference Coverage
Premenopausal age linked to lower sexual function after gynecologic cancer surgery
INDIAN WELLS, CALIF. – Premenopausal age was associated with a greater temporary decline in sexual desire 1 month after undergoing surgery for...
Conference Coverage
ACOSOG Z0011: Good long-term results with SLND without ALND
CHICAGO – Sentinel lymph node dissection without axillary lymph node dissection offers excellent regional control in select patients with early...
Conference Coverage
Surgery has edge over surveillance for micropapillary thyroid cancer
BALTIMORE – Endocrinologists and surgeons need to have in-depth conversations with their patients to determine their level of anxiety about having...
Conference Coverage
Merkel cell carcinoma responds to first-line pembrolizumab
Key clinical point: Rare Merkel cell carcinoma responds well to immunotherapy with pembrolizumab. Major finding: The response rate was 56%, all...
Conference Coverage
Neoadjuvant chemotherapy improves survival for some with pancreatic cancer
Key clinical point: Overall survival in stage III pancreatic cancer was better with neoadjuvant chemotherapy. Major finding: Median survival with...
Conference Coverage
Change in T-cell distribution predicts LFS, OS in AML
NEW ORLEANS—A phase 4 study has revealed biomarkers that appear to predict the efficacy of treatment with histamine dihydrochloride (HDC) and...